RAMGNAmgen Tokenized Stock (Reality)
Stock 24/7/365Issued by Reality
Amgen Inc. is a pioneering global biotechnology leader specializing in the discovery, development, and high-volume manufacturing of human genetics-based biologics. The company commands dominant therapeutic portfolios in bone health (Prolia), cardiovascular conditions (Repatha), and biosimilars. Backed by vast regulatory moats and steady cross-cycle pricing power, it functions as a highly defensive income-generating pharma asset.
- Macro context: RAMGN is part of the tokenized equities market, which represents only ~0.002% of global listed equity today.
Data as of Nov 1, 2026
Price performance
7D
+5.14%
14D
+9.48%
30D
—
1Y
—
All-time
+22.75%
Key facts
via /coins/{id}Market Cap Rank
#11137
Circulating Supply
25.31
Total Supply
25.31
All-Time High
$473.55 · 2026-10-29
Categories
News & Insights
Also tokenized by
Amgen Tokenized Stock (Reality) is issued as 3 separate tokens across different issuers.
| Issuer | Token | Price | Market Cap | 24h Volume | Networks |
|---|---|---|---|---|---|
| Ondo Finance | $475.45 | $7.77K | $153.61K |    | |
| xStocks | AMGAMGNX | — | — | — | — |
AMGNONAlerts & digests
Coming soonReal-time price, NAV, mint, redemption alerts
Get pinged the moment RAMGN crosses a price or spread threshold you set, or automated.
Breaking news alerts
Issuer, regulatory and depeg news for RAMGN — the second it drops.
Daily summary
A once-a-day digest of RAMGN's price, best yield and market moves in your inbox.
Analyze & download 24/7 history
Full round-the-clock historical data for RAMGN — including off-market-hours — exportable to CSV.
Analyse with insight & news
AI-assisted analysis of RAMGN paired with the latest issuer, regulatory and market news.